ABSTRACT
Obstructive episodes are usually accompanied by loud snoring and a drop in blood oxygen saturation (hypoxemia), ending in short micro-awakenings, which result in sleep fragmentation 4 . Sleep basically consists of two moments that alternate between waking states: non-rapid eye movement (NREM) and rapid eye movement (REM). Sleep apnea events last longer and have higher hypoxemia during REM sleep than during NREM sleep in patients with OSAS 5 . According to Jauhar et al. 2 , the deterioration of sleep quality caused by OSAS significantly contributes to excessive daytime sleepiness, loss of cognitive capacity, and mood swings and personality changes. It has also been associated with a worsening in the quality of life and in relationships with spouses and partners, decreased alertness, and an increased risk of traffic accidents. In addition, there are indications of an increase in cardiovascular diseases among untreated OSAS patients, and it is a potentially life-threatening condition
INTRODUCTION
The recognition of respiratory disorders during sleep has been increasing each year in the field of medicine, and it has aroused the interest of dentistry in obstructive sleep apnea syndrome (OSAS), the most common of these disorders, which affects 4% of middle-aged men and 2% of middle-aged women 1 . OSAS is considered to be a major public health issue 2 and is a chronic condition characterized by recurrent episodes of obstruction of the upper airways (UA) during sleep, leading to a significant reduction (hypopnea) or total blockage (apnea) of the airflow for at least 10 s. These events occur because of the collapse of pharyngeal tissues, resulting from the combination of a reduction in the muscle tone of the tongue and pharynx, changes in respiratory control, the supine position, and decreased pharyngeal space in susceptible individuals 3 .
palate than that of healthy individuals. Battagel & L'Estrange 3 also confirmed that the dimensions of the retropalatal space of the oropharynx are significantly reduced and the tongue is proportionately wider. According to the authors, these factors cause narrowing of UAs, which may be aggravated by the degenerative relaxation of the soft tissues that occurs with increasing age, and they are most pronounced in the supine position during the overall relaxation of sleep. Treatment of OSAS is primarily based on the degree of severity indicated by AHI, which must be considered together with the clinical signs and symptoms, any existing morbid consequences, clinical and radiographical craniofacial characteristics, and the condition of the mouth as well as any added risk factors such as obesity, smoking, and alcohol consumption.
The main non-invasive treatments described in the literature are continuous positive airway pressure (CPAP) and intraoral devices (IODs). The former is a therapeutic method for treating all levels of OSAS. It consists of a nasal mask connected to a motor that pumps air at a positive and continuous pressure, opening UA and preventing the collapse of the pharyngeal tissues. IODs are a relatively recent development, being indicated more often for mild to moderate cases of OSAS 2, [16] [17] [18] [19] . IODs are divided into two types: a) tongue retainer devices, proposed by Cartwright & Samelson 20 , which hold the tongue in a more forward position, promoting better opening of UAs, and b) mandibular advancement devices (MADs), which keep the jaw protruding, increasing the dimension of UAs, including the hypopharynx, oropharynx, and nasopharynx. This action improves the airflow and reduces the possibility of respiratory blockage 21 . Both CPAPs and IODs are effective in relieving symptoms, improving excessive daytime sleepiness, quality of life, and several aspects of neurocognitive function in patients with AHI from 5 to 30 22 . Although CPAP is extensively used in the treatment of OSAS, some patients are reluctant to use them or are unable to tolerate them, preferring IODs 23 . In this context, dentistry has been increasingly responsible for treating cases of OSAS that have been prescribed IODs. The growing need of dentists experienced in performing this treatment method enlarges the scope for these professionals because they specialize and recognize the need for a correct and careful approach for patients with OSAS who are referred to the dental clinic.
The aim of this study is to describe a case report of OSAS and to describe a logical sequence for the treatment of patients who suffer from this disease.
Polysomnography (PSG) is considered to be the gold standard among diagnostic exams for OSAS. Conducted in a sound lab where the patient is monitored while he/she sleeps, it records several variables over a period of time. The minimum required tests recorded are the electroencephalogram (EEG), electrooculogram (EOG), and submental electromyogram (EMG). Additional parameters are required for an evaluation of sleep-related respiratory disorders such as nasal-oral airflow, in addition to oximetry (which measures arterial oxygen saturation), electrocardiogram, snore and body position sensors, and an electromyogram of the legs 8 . According to the American Academy of Sleep Medicine (AASM), a diagnosis of OSAS is established when PSG detects the occurrence of at least five apnea and/or hypopnea events/h of sleep, expressed through the Apnea and Hypopnea Index (AHI). This index also classifies the degree of severity of OSAS according to the following scale: 5 to 15, mild; 15 to 30, moderate; and >30, severe. Hypopneas are only considered in the AHI calculation when there is a >50% reduction in the airflow, accompanied by >3% blood oxygen desaturation or micro-awakenings 9 . In addition to checking AHI, the existence of clinical signals related to excessive daytime sleepiness, loud snoring, and other signs and symptoms related to sleep apnea should be considered during diagnosis and treatment.
According to Strobel & Rosen 10 , obesity is a significant risk factor related to the development of OSAS or an increase in its severity. Fat deposits around the neck tend to narrow the pharyngeal region, increasing the possibility of UA collapse. The body mass index (BMI) is the product of a calculation related an individual's weight and height, indicating an overweight condition. Other OSAS risk factors such as alcohol consumption 11 and smoking 12 need to be considered because they produce greater muscle relaxation, facilitating the occurrence of collapse. The position of the body while sleeping also influences the frequency of apnea and hypopnea. In many cases, AHI increases in dorsal decubitus and decreases in the lateral position 13 . Since the elucidation of the physiopathology of OSAS, cephalometric analyses have revealed that compared with healthy individuals, patients affected by OSAS have craniofacial differences 14 . In 1991, Rintala et al. 15 reported on points, planes, angles, and linear measurements most commonly used in cephalometric tracings of patients with OSAS. The usually found characteristics are mandibular retrognathia in relation to the cranial base and maxilla, a greater than normal perpendicular distance from the hyoid bone to the mandibular plane, and a longer and thicker soft Obstructive sleep apnea syndrome
CASE REPORT
This study was approved by the Research Ethics Committee, with protocol number 08.284.4.02.III. A male patient (46 years old, married, non-smoker, occasional alcohol drinker) who was diagnosed with OSAS was complaining of a lack of concentration, daytime sleepiness, and irritability. His wife reported that his extremely heavy snoring was negatively affecting their relationship. The patient's BMI was 29.4, classified as overweight (BMI between 25.0 and 29.9). In the PSG report, AHI of 17.6 was noted, with apneas and hypopneas, a predominance of obstructive events during REM sleep (39.6 events/h), snoring during 31.2% of the total sleep time (TST), mostly dorsal decubitus, minimum blood oxygen saturation of 89%, micro-awakening index of 14.2 events/h, and sleep efficiency of 90.1%. No significant electroencephalographic or electrocardiographic changes were observed.
The clinical examination confirmed the presence of 24 teeth (Figure 1 ) with good periodontal support and no mobility of the elements. The patient was not undergoing dental treatment or intending to begin any prosthetic planning. The patient reported no pain. Teleradiography of the profile was requested, and cephalometric tracing and analysis for sleep apnea were performed.
After evaluation of the values obtained in the cephalometric tracing (Table 1) , the presence of a higher number of favorable than unfavorable measurements was considered for performing therapy using IOD.
Two impressions were made of both the upper and lower jaws to obtain study and work models. The work models were associated by means of an occlusal registration using the George Gauge 24 (Great Lakes Orthodontics, Tonawanda, USA) together with sheets of Figure 2 . Registration of the interocclusal relationship using the George Gauge and wax #7 sheet white wax #7 (Epoxiglass, Diadema, Brazil). A maximum protrusion (MP) of 11 mm was measured using this device. The possible mandibular advancement for IOD, which should be 80% of MP, was then calculated 25 , equivalent to 8.8 mm in this case. The George Gauge was attached in this new position, wrapped in a sheet of wax in the area of the occlusal fork, and placed between the jaws of the patient, who was instructed to bite down slowly (Figure 2 ). During the installation of the device (Figure 5 ), the patient received instructions about the use and maintenance of the device and was informed of the need for subsequent clinical follow-up.
A PLG device 26 ( Figure 3 ) was constructed, which enables gradual mandibular advancement through the activation of dorsal arches (Figure 4) , freedom of lateral, protrusive movement, and stabilization of the mandible. the device. The additional advancements of 1 mm each were made at 15-day intervals.
After 4 weeks of using the device, the patient underwent another polysomnography, with the device in position this time.
The examination revealed AHI of 4.1 and an absence of apnea, with the majority of obstructive events occurring during REM sleep, although with a significant improvement (11.7 events/h). In addition, a reduction in the intensity, if not the percentage, of snoring was observed. Dorsal decubitus was predominant, minimum blood oxygen saturation was 90%, the micro-awakening index was 10.7/h, and sleep efficiency was 91.8%. No significant electroencephalographic or electrocardiographic changes were observed. BMI remained the same following treatment with PSG.
The cephalometric radiograph, PSG data, study models, and photographs were archived for future reference and for use as control during follow-up appointments that would be conducted at 6-month intervals during the first year and annually thereafter.
This clinical study was conducted after clarification to the patient and the signing of an informed consent form.
DISCUSSION
According to AASM, the treatment goals for patients with apnea are resolution of the clinical signs and symptoms of apnea and normalization of AHI and blood oxygen saturation 16 . In this case, the main objectives described above were achieved. The main results were the improvement of clinical signs and symptoms, particularly in terms of the patient's daytime sleepiness and lack of concentration, and the reports of loud snoring made by his wife. The initial AHI of 17.6, representing a moderate level of apnea, fell to 4.1 (normal < 5 events/h), and the saturation of oxyhemoglobin rose from 89% to 90%, remaining practically stable, as demonstrated by the second polysomnograph with the device in position, a practice also recommended by AASM 16 . Many studies have reported the use of IODs to treat mild (AHI = 5 to 15) and moderate (AHI = 15 to 30) OSAS, with proven short-and long-term efficacy 2, [17] [18] [19] 27 . It is important to emphasize that the dental surgeon must not base a decision regarding whether this device is the best treatment option for the patient solely on the basis of this index, even in cases where a referral already comes with this indication. Verifying the signs and signals, analyzing the PSG data, performing extraoral and intraoral 14 , a request for profile cephalometric radiography and subsequent analysis focused on obstructive sleep apnea should undoubtedly be included in the diagnosis-treatment protocol of OSAS. They observed that a short mandible, narrow posterior airway, long soft palate, and low positioning of the hyoid seem to be the most significant parameters encountered in patients with OSAS. According to Mayer & MeierEwert 28 , these and other cephalometric findings specific to obstructive sleep apnea will act as indicators of the possibility of success with IODs.
In our case, the patient had a slightly decreased mandibular length (79.0 mm/Normal: 84.5 mm ± 5), increased soft palate length (54.0 mm/Normal: 34.0 mm ± 5), decreased posterior pharyngeal space (9.5 mm/Normal: 15.5 mm ± 3.5), and increased hyoid-mandibular plane distance (28.5 mm/Normal: 19.0 mm ± 6), indicating a lower positioning of the hyoid, corroborating the most commonly encountered cephalometric findings in patients who suffer from obstructive sleep apnea 3, 14 . Of the values obtained by cephalometry in this case, the maxillary length and soft palate length were considered to be unfavorable to IOD therapy because they reduce the efficiency of the mode of action of the device. However, the other values were considered to be favorable to this treatment modality, which helped in the decision-making process.
MAD uses the teeth to anchor it in the mandibular protrusion, and according Johal & Battagel 29 , it increases the size of the airway, stretching the tongue and the soft palate forward and maintaining airflow in UA during sleep. However, MAD is not indicated in all cases, making a clinical examination necessary because according to Shoaf 7 , to retain the device, the patient must have at least eight healthy teeth in each jaw without the presence of active periodontal disease or increased movement of the teeth. In his study, he also states that patients with a history of temporomandibular dysfunction (particularly chronic pain) would not adapt to the device because the protrusive positioning can lead to a recurrence or increase in pain in the temporomandibular joint (TMJ).
Given the chronic nature of OSAS, the adverse effects of long-term treatment should be considered.
The study by Hammond 17 , in which 185 patients were interviewed before and after beginning treatment with MAD, corroborated prior studies, which found that adverse effects from the use of MAD over long periods of time are common, although they are mild and welltolerated by most patients. Almeida et al. 6 observed favorable dental changes in almost half of the patients who had been using IODs for an average of 7.4 years. According to the results of Almeida et al. 30 , IODs induced teeth movement but no craniofacial skeletal changes. In 2005, because of existing concerns regarding adverse events, the Standards of Practice Committee of AASM published practical guidelines for treatment using IODs in patients with obstructive sleep apnea, in which they recommended follow-up every 6 months during the first year of treatment and annually thereafter 16 . According to these practical guidelines, the purpose of follow-up is to monitor adherence, evaluate deterioration of the device, adjust the device, assess the health of the structures of the mouth and the integrity of the occlusion, and determine whether the signs and symptoms of apnea have worsened.
Almeida et al. 6 concluded that because the use of IODs for OSAS is a long-term treatment and because the changes appear to continue over time, archiving cephalometric radiographs, study models, and preand post-treatment intraoral photographs should be encouraged in all clinical protocols for the use of IODs.
CONCLUSION
The dental surgeon should not begin the treatment of referral patients with OSAS using IOD without checking the radiographic, clinical, and polysomnographic characteristics relevant to a correct indication of this therapy.
The case history, clinical examination, and analysis of the initial cephalometric and polysomnographic tests as well as subsequent request for and interpretation of a second polysomnographic examination (using IOD) are essential for the proper approach and follow-up of apneic patients.
The presented approach ensured successful treatment in this case.
